USP 797 Sterile Compounding Practice Test

These questions are part of the practice quiz. Start practicing

• What is the main aim of performing regular testing on ACDs?
• What is a significant reason for changing gloves during the compounding process?
• Which aspect is vital for maintaining sterility during transport of compounded sterile preparations?
• How often should accuracy or precision testing be performed on ACDs?
• What is the frequency for surface sampling in a cleanroom according to USP 797?
• Which of the following must be included in a CSP’s label?
• What should be prioritized when developing a sterile compounding policy?
• Which of the following indicates a Low risk level in compounding?
• What is the purpose of hand hygiene in the compounding process?
• What is the focus of risk assessment in sterile compounding?
• Which clean room environment is preferred for community pharmacies?
• What factor is essential when evaluating the effectiveness of cleaning procedures?
• Which of the following is a common route of contamination in sterile compounding?
• Which statement best describes the purpose of personal protective equipment in sterile compounding?
• Which of the following statements about CSPs and auxiliary labels is true?
• Why is proper storage of compounded sterile preparations vital?
• Which of the following is a critical area of focus regarding patient safety in CSP compounding?
• What is a crucial factor to ensure when compounding sterile preparations?
• What is the expected outcome of applying USP 797 standards?
• How should waste materials be handled in a sterile compounding setting?
• What does "aseptic technique" refer to in sterile compounding?
• What is the implication for patient and/or caregiver training in regards to written procedures?
• Which of the following is a primary type of sterile compounding environment?
• What is another name for a barrier isolator?
• What does the term 'beyond-use date' refer to?
• What is the primary focus of USP 797 standards?
• What is the minimum number of air changes per hour required in the cleanroom area?
• Define "compounding."
• What is the correct duration for running LAFW blowers before compounding?
• What is a key responsibility of a sterile compounding supervisor?
• At a minimum, how often should qualified personnel test laminar airflow workbenches?
• Which of the following statements is true regarding the use of PPE in sterile compounding?
• Which strategy is effective in preventing cross-contamination in sterile compounding?
• What is the main goal of maintaining proper airflow in the sterile compounding area?
• What does proper training in sterile compounding help staff to achieve?
• What is the correct order of garbing for compounding sterile preparations?
• What information must patients and/or caregivers be able to describe regarding CSPs?
• What does "environmental monitoring" refer to in sterile compounding?
• Describe the proper method for cleaning the work surface in a cleanroom.
• Describe the purpose of environmental monitoring in sterile compounding.
• How often should environmental monitoring be performed in compounding areas as per USP 797?
• What should be done if contamination is suspected in a compounded preparation?
• What is the maximum incidence allowed for a healthcare worker to potentially introduce contamination during CSP preparation?
• Which practice is essential for maintaining sterility in compounding?
• What is the correct risk level for compounded sterile preparations that are simple and straightforward?
• What action should be taken if contamination is suspected in a compounded sterile preparation?
• What is the minimum handwashing duration recommended before compounding?
• What is one responsibility of the pharmacist concerning the handling of CSPs?
• Who is primarily responsible for ensuring compliance with USP 797 standards?
• What should the air quality be in an ante-area used for sterile compounding?
• What must appear on the label for prescriptions intended for home care patients?
• What measures can prevent allergic reactions during sterile compounding?
• In which type of environment is sterile compounding typically performed?
• What is the impact of temperature on sterile compounding?
• Which method is recommended for ensuring aseptic preparations in a pharmacy setting?
• What role do standard operating procedures (SOPs) play in sterile compounding?
• What should be done immediately if a sterile preparation is observed to be contaminated?
• In sterile compounding, what do we call the area where sterile compounding activities occur?
• Should CSPs not immediately dispensed be refrigerated?
• Why is hand hygiene particularly important in sterile compounding?
• Should administrative personnel be assigned to answer patient questions instead of pharmacists?
• When should a compounded sterile preparation (CSP) be discarded?
• What is one of the primary goals of USP 797 guidelines?
• Who should be responsible for following and enforcing SOPs in sterile compounding?
• What are the potential results of improper garbing techniques?
• Is it necessary for standard operating procedures to be in place for reporting adverse events?
• What risk level is assigned to preparations made from non-sterile ingredients?
• Is there a specific time frame established for reviewing reports of adverse events?
• Which statement is true regarding aseptic techniques in compounding?
• Why is it crucial to document compounding activities?
• Are the labels on patient-specific CSPs and batch-prepared CSPs the same?
• Jewelry can be worn in the compounding area as long as the wearer is properly gowned. What is the correct answer?
• What aspect of sterilization is crucial in ensuring patient safety?
• Which factor contributes to determining the risk level of a compounding process?
• What is the role of the PPE donning and doffing procedure?
• What defines a Category 1 CSP?
• Why is it essential to document compounding processes and incidents?
• What is necessary for patient and/or caregiver training in handling CSPs?
• What must be maintained daily for refrigerator, freezer, and incubator temperatures?
• What should personnel do upon identifying a breach in sterile technique?
• Must a CSP label always include an auxiliary label?
• Which of the following is NOT a critical step in sterile compounding?
• What is the main focus of training related to sterile compounding?
• What is a critical factor in determining the potency of a compounded preparation?
• Which of the following practices is essential for maintaining a cleanroom environment?
• Why is the use of personal protective equipment (PPE) critical in sterile compounding?
• What is an essential practice in ensuring the quality of compounded sterile preparations?
• What is the risk level assigned to preparations exposed to high air quality risks?
• Why is it important to document the BUD of a CSP?
• Is it acceptable for technicians to compound even if training is not completed?
• Who is responsible for ensuring the end user knows how to properly store CSPs?
• Why is utilizing sterile equipment crucial in sterile compounding?
• What defines low-risk level compounding?
• Should all quality assurance programs for compounding facilities be standardized for consistency?
• Why is validating cleaning and disinfection processes important in sterile compounding?
• In which situation must a Category 2 CSP be prepared?
• What are the potential risks of non-compliance with USP 797 standards?
• When preparing CSPs, how does the aseptic technique of the patient or caregiver compare to that of pharmacy personnel?
• Which type of documentation provides general instructions on activities such as gowning?
• How can environmental contamination be managed in sterile compounding areas?
• What is the correct action if a CSP is observed to have an unusual color or precipitate?
• Which category describes a procedure that is not intended for continuous use and is for immediate patient needs?
• What is the purpose of a cleaning log in sterile compounding?
• When ACDs are used regularly, how often should they be calibrated?
• Which of the following is not caused by the presence of endotoxins in a CSP?
• Are drains or sinks acceptable in the buffer area?
• If a laminar airflow workbench is turned off between aseptic processing sessions, how long should it run before it is used?
• What is the purpose of end-preparation testing for high-risk level compounded sterile preparations?
• What is the containment primary engineering control (C-PEC) used for?
• What are the three categories of compounded sterile preparations (CSPs) defined by USP 797?
• What is a "CSP risk level"?
• For high-risk level compounding, when is additional end-preparation testing required?
• Which of the following is a factor to consider in aseptic processing?
• What is a key requirement for home care patient labels?
• How should a pharmacy address the disposal of hazardous waste in sterile compounding?
• Why is a cleanroom crucial in sterile compounding?
• What consequences may arise from poor aseptic technique in compounding?
• What is true regarding the frequency of performing accuracy/precision testing on ACDs?
• What should compounding personnel do if they are ill?
• What type of airflow is crucial in a cleanroom environment for sterile compounding?
• What is the key difference between cleaning and disinfecting in sterile compounding?
• What requirement must non-pharmacy personnel fulfill when transporting CSPs?
• Which ISO class is considered clean air for a sterile compounding area?
• How do ACDs impact the compounding process compared to traditional methods?
• What aspect is essential for maintaining the integrity of sterile compounded preparations?
• What should be done in the event of a contamination incident in a sterile compounding area?
• What is the role of monitoring in ensuring compliance with USP 797 regulations?
• Which organization sets the standards for sterile compounding practice?
• What is considered a critical factor in maintaining the quality of sterile preparations?
• How often must training be conducted for personnel doing high-risk level compounding?
• How critical is the training of pharmacy staff in the sterile compounding processes?
• Which personal protective equipment (PPE) is mandatory during the compounding process?
• Which of the following are common types of sterile drug products prepared in compounding pharmacies?
• For which of these compounding activities is the use of a glove box unsuitable?
• Are there limits to the number of CSPs that may be compounded at a time?
• Who is responsible for ensuring that all compounding personnel are properly trained and evaluated?
• What is the main purpose of USP 797?
• What is the importance of using sterile diluents in sterile compounding?
• What should be done if an error occurs during the compounding process?
• If using an automated compounding device, how long must reports be kept?
• What is crucial for maintaining a cleanroom's pressure differentials?
• How should excess ingredients be handled after compounding?
• Which personnel should participate in ongoing training regarding aseptic techniques?
• In sterile compounding, what role does an auxiliary label serve?
• Does a quality assurance program need to be documented formally in writing?
• How long must annual and routine maintenance reports be kept on file?
• What should be done with compounded products that exceed their BUD?
• What is the role of compounding records?
• What is the risk of compound storage exceeding beyond the assigned beyond-use date (BUD)?
• What is the main purpose of USP 797 standards?
• How can technology improve safety in sterile compounding?
• In a sterility test, how long are samples incubated in growth medium?
• Sterile ingredients, components, devices, and mixtures are exposed to air quality inferior to which ISO class?
• What are the risks associated with using expired ingredients in compounding?
• What should be done to enhance workflow efficiency in sterile compounding?
• Which characteristic is critical for a space to be classified as a cleanroom?
• How is the appropriate beyond-use date for a compounded sterile preparation determined?
• What is the role of the quality assurance program in a sterile compounding pharmacy?
• Compounding occurs in which ISO class environment at all times?
• How are "critical sites" defined in sterile compounding?
• What is a key characteristic of a "high-risk" compounding process?
• How can contamination of a CSP be minimized during compounding?
• Which of the following statements regarding the maintenance of ACDs is false?
• What is necessary to ensure consistency in determining beyond-use dates?
• How does risk assessment contribute to sterile compounding?
• Who is ultimately responsible for the proper packaging, handling, transport, and storage of CSPs?
• What should a pharmacist do if they find a CSP with visible foreign particles?
• How often should sterility testing be conducted for compounded sterile preparations?
• Is the assignment of administrative personnel to handle patient inquiries viewed as acceptable?
• Describe what an environmental risk assessment entails in sterile compounding.
• What is the purpose of a media-fill test in sterile compounding?
• What is the role of a Quality Assurance (QA) program in sterile compounding?
• What does the term "compounding" refer to in the context of pharmacy?
• What is the primary role of a sterile compounding technician?
• Does only medium and high-risk level compounding require a double-check system before a CSP can leave the Pharmacy?
• How should CSPs that require reconstitution be handled?
• Which environmental condition is essential for maintaining sterility during compounding?
• Once a multi-dose vial (MDV) has been opened, what is the maximum beyond-use date unless otherwise specified?
• How strict are the aseptic preparations performed by patients or caregivers when compared to those conducted by pharmacy personnel?
• Why is it important to maintain proper airflow in a sterile compounding environment?
• What does "aseptic processing" primarily aim to prevent?
• How often should air sampling and surface sampling be conducted in sterile compounding areas?
• Why is training important for staff involved in CSP compounding?
• What is the required ISO classification for the buffer area in sterile compounding?
• Why is documentation critical in the sterile compounding process?
• How often should pharmacists visually inspect compounded sterile preparations (CSPs)?
• What is the common method for sterilizing equipment in sterile compounding?
• When should a first air source be established in an ISO Class 5 environment?
• What should a compounding technician do if they receive outdated materials?
• Is it acceptable for patients and caregivers to prepare CSPs at home without training?
• When should sterile compounding personnel perform competency assessments?
• What does aseptic technique involve in sterile compounding?
• What is a primary role of cleaning and disinfecting in a sterile compounding environment?
• What is the definition of a "cleanroom" according to USP 797?
• What is the risk level associated with compounding that involves non-sterile ingredients?
• Which method is recommended to ensure sterility in compounded preparations?
• How often should the HEPA filters of a PEC be certified?
• Which statement is true regarding the necessity for auxiliary labels on CSPs?
• What should be done with CSPs that have visible defects?
• What precautions should be taken when handling hazardous drugs in sterile compounding?
• How many units within a batch need to be tested to ensure absolute sterility?
• What aspects must the pharmacist educate patients and caregivers about regarding CSPs?
• What is considered a "critical site" in the context of compounding?
• How do sterile gloves contribute to safe compounding practices?
• What is classified as 'high-risk' CSP?
• What is essential for ensuring proper personnel training in safe sterile compounding?
• Why is curriculum important in staff training for sterile compounding?
• What are the major criteria for proper hand hygiene in sterile compounding?
• Why is routine equipment maintenance important in sterile compounding?
• Is formal documentation needed for adverse event reporting procedures?
• In what situations should a compounding facility undergo a thorough re-evaluation?
• Are patients required to be clinically monitored when receiving CSP through a home care delivery system?
• What are beyond-use dates (BUDs) in sterile compounding?
• What is the function of a classified area in a sterile compounding facility?
• What is the maximum beyond-use date for frozen CSPs at all risk levels?
• What is the purpose of process verification in sterile compounding procedures?
• Is it acceptable to compound a CSP for a patient who has been discharged?
• Which of the following best describes a "low-risk" compounding process?
• What is the purpose of sterilization in sterile compounding?
• What role does monitoring air handling systems play in a cleanroom?
• What is one major risk when proper hand hygiene is not observed in sterile compounding?
• Which of the following is generally required for medium-risk compounding?
• Which of the following is NOT a key component of aseptic technique?
• What is the significance of a biological safety cabinet (BSC) in sterile compounding?
• What is the correct guideline regarding the temperature of Compounding Sterile Preparations (CSPs) during transit?
• What is the primary purpose of a laminar flow hood?
• What is another name for a media-fill test?
• What is the required ISO classification for the primary engineering control (PEC) used in preparing Category 2 CSPs?
• What is the proper technique for opening sterile vials during compounding?
• What is the primary reason for performing visual inspections of compounded sterile preparations?
• What is a key aspect that differentiates Category 3 CSPs from Category 1 and Category 2?
• How frequently should ACD daily performance records be evaluated according to best practices?
• Which statement is true about changes in ACD operations?
• What is a key component in preventing contamination during compounding?
• How often should a cleanroom suite be cleaned?
• When should gloves be changed during the compounding process?
• What is the BUD for a CSP stored at room temperature?
• What protocol should be followed for equipment cleaning in sterile compounding?
• Why is it critical to maintain temperature logs for CSPs?
• What can result from improper handling of sterile compounding equipment?
• Which of the following best describes the role of the ante-area in sterile compounding?
• What risk level is assigned to multiple pooled sterile commercial preparations for either multiple patients or one patient multiple times?
• For how long should the LAFW blowers run before starting compounding activities?
• Why is training and competency assessment essential for personnel involved in sterile compounding?
• What steps should be taken if a compounded sterile preparation is found to have a defect?
• What factors influence the determination of a beyond-use date (BUD)?
• How does physical layout affect infection control in sterile compounding?
• How should the sterility of compounded preparations be evaluated?
• Which of the following actions should be taken if a CSP is exposed at room temperature for longer than specified limits?
• What is the role of quality assurance in the context of USP 797?
• What does "beyond-use date" (BUD) indicate?
• What risk level is usually associated with a preparation that has no bacteriostatic agents added and is administered over several days?
• What is the purpose of the primary engineering control (PEC) in sterile compounding?
• What must patients and/or caregivers demonstrate under direct supervision when it comes to aseptic technique?
• Can adverse event reports be filed without a specific time frame?
• What do the categories "low, medium, and high-risk" signify in the context of USP 797?
• How often should personnel perform glove fingertip testing?
• Who bears the ultimate responsibility for training patients and caregivers on CSPs?
• What is the first step in preparing a compounded sterile preparation?